Targeting the High Mobility Group Box 3 Protein Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin

Cancer Research - United States
doi 10.1158/0008-5472.can-19-0542
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Blockage of Cisplatin-Induced Autophagy Sensitizes Cervical Cancer Cells to Cisplatin

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2015English

Targeting HSF1 Sensitizes Cancer Cells to HSP90 Inhibition

Oncotarget
Oncology
2013English

Targeting High Mobility Group Box-1 (HMGB1) Promotes Cell Death in Myelodysplastic Syndrome

Clinical Cancer Research
Cancer ResearchOncology
2019English

Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics

Journal of Ovarian Research
GynecologyOncologyObstetrics
2010English

Ginkgo May Sensitize Ovarian Cancer Cells to Cisplatin

Integrative Cancer Therapies
OncologyAlternative MedicineComplementary
2012English

Silencing of CXCR4 Sensitizes Triple-Negative Breast Cancer Cells to Cisplatin

Oncotarget
Oncology
2014English

High-Mobility Group Box 1 Protein (HMGB1) Neutralization Ameliorates Experimental Autoimmune Encephalomyelitis

Journal of Autoimmunity
AllergyImmunology
2013English

Knockdown of Cathepsin�L Sensitizes Ovarian Cancer Cells to Chemotherapy

Oncology Letters
Cancer ResearchOncology
2016English

ABT737 Reverses Cisplatin Resistance by Targeting Glucose Metabolism of Human Ovarian Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy